Infusion Nursing Notes by Nufactor provides education, resources and support to promote successful patient therapy within the infusion nursing community.

Managing Infusion Side Effects - Who to Call and When

Timely recognition and communication of side effects during IVIg or SCIG therapy is essential to patient safety and treatment adherence. Reactions vary by patient and can range from mild to severe. As the nurse, you are often the only clinician physically present during infusions—your assessments and communication are critical in managing the patient’s care. If side effects are not managed appropriately and tolerability becomes an issue, the patient may want to stop therapy, which could impact the management of their condition. The following is a guide to help you determine who to call and when. [More]

IVIG Pooling: Weighing the Pros and Cons in Home Infusion

Pooling Intravenous Immune Globulin (IVIG) has become a topic of discussion among healthcare professionals, especially in home infusion therapy (HIT). In the dynamic field of healthcare, particularly in HIT, the importance of adhering to established standards cannot be overstated. This blog will provide insights into pooling IVIG and describe advantages and disadvantages of pooling based on guidelines from the Infusion Nurses Society (INS) and the Immunoglobulin National Society (IgNS). By aligning our practices with these recognized standards, we can enhance patient safety, improve outcomes, and ensure the highest quality of care. [More]

How to Use the IG Side Effects Card

Prior to an infusion visit, we ask nurses to contact patients 12 -24 hours before and complete our Pre-Infusion Checklist (IVIG Pre-Infusion Checklist / SCIG Pre-Infusion Checklist). Nufactor developed the checklist to help the nurse and patient plan for a successful infusion. The list is a great tool and helps nurses guide their patients using a standardized check-off format. The list provides tips to give to the patient the day prior to, the day of, and the day after an infusion. [More]

Infliximab, Biologics: Infusion Precautions

Biologics products have been developed to treat undesirable immune responses caused by chronic systemic inflammatory conditions. The immune system consists of a vast network of cells, tissues and organs that all perform specific functions to help keep the “host” in a state of equilibrium. Infliximab is a monoclonal antibody tumor necrosis factor α (TNF) inhibitor. That has been used to slow the progression of several inflammatory conditions, such as rheumatoid arthritis by blocking the activation of TNF, target specific therapy. [More]

Managing IVIG-Related Side Effects

Intravenous Immune Globulin (IVIG) infusions are generally well tolerated. Most associated side effects are mild and managed with multiple approaches which may include pre-medication, clinical consultation providing education on what to expect with infusion, ongoing monitoring of infusions, and modifications to the individualized patient infusion protocol if side effects occur. [More]

Management of SCIG Side effects

The greatest advantage of subcutaneous immunoglobulin (SCIG) is that it provides the patient with autonomy, which helps them feel empowered to live a normal life. Nurses are responsible for teaching patients how to manage the expected side effects. Most patients do not require premeds; if they are ordered, advise your patient to be compliant with them. Always ensure the anaphylaxis kit is readily available for each infusion regardless of past tolerability. It should consist of a double pack epinephrine autoinjector and oral Benadryl. Please instruct the patient how to use it properly before leaving their home. [More]